Insulin Aspart + Insulin Degludec
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Insulin Aspart
insulin-aspart - Insulin Degludec
insulin-degludec
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| RYZODEG FLEXTOUCH SOLUTION FOR INJECTION IN PRE-FILLED PEN 100U/ML 70/30HK | — | NOVO NORDISK HONG KONG LIMITED |
| Ryzodeg PenfillAU | 70 unit / 30 unit | Novo Nordisk Pharmaceuticals Pty. Limited |
| Insulin degludec + insulin aspartAU | 70 unit / 30 unit | Novo Nordisk Pharmaceuticals Pty. Limited |
| insulin aspart + insulin degludecAU | — | — |
| 諾胰得 諾特筆TW | — | 台灣諾和諾德藥品股份有限公司 |
| Ryzodeg® FlexTouch®TW | — | 台灣諾和諾德藥品股份有限公司 |
| RYZODEG® FLEXTOUCH® SOLUTION FOR INJECTION IN PRE-FILLED PEN 100 U/mlSG | 180 nmol/mL / 420 nmol/mL | NOVO NORDISK PHARMA (SINGAPORE) PTE LTD |
| RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridgeAU | 420 nmol/mL / 180 nmol/mL | Novo Nordisk Pharmaceuticals Pty Ltd |
| RYZODEG 70/30 PENFILL 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridgeAU | 180 nmol/mL / 420 nmol/mL | Novo Nordisk Pharmaceuticals Pty Ltd |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.